Most Read Articles
one year ago
Dr Lesley Braun, Blackmores Institute Director, is interviewed and answers some critical questions on complementary medicine, its evolution, its benefits and its present and future roles alongside mainstream medicine.
Pearl Toh, 11 days ago
Elderly persons (≥75 years) on aspirin-based antiplatelet therapy without routine proton-pump inhibitor (PPI) use have a higher long-term risk of major bleeding, in particular upper gastrointestinal (GI) bleeding which is often more disabling or fatal than in younger persons, according to the OXVASC* study.
Pearl Toh, 2 months ago
Celecoxib is preferred over naproxen when added to proton-pump inhibitor (PPI) for preventing recurrent upper gastrointestinal (GI) bleeding in patients at high risk of both GI and cardiovascular (CV) events, who require concomitant aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), according to the CONCERN* study.
one year ago
Bicalutamide plus everolimus is a promising treatment for patients with castration-resistant prostate cancer (CRPC), based on a phase II clinical trial.

Bio-Oil celebrates 10th anniversary in Malaysia

Saras Ramiya
3 months ago
(L-R) Dr. Nazirin Ariffin, Low Hooi Wan and Stephanie Ng, product manager, Nuvanta Sdn Bhd, at the recent Bio-Oil 10th anniversary high tea.

After being introduced to Malaysia 10 years ago, Bio-Oil has established itself as a staple skincare brand.

Bio-Oil specializes in caring for a variety of skin conditions ranging from scars, stretch marks and uneven skin tone to ageing and dehydrated skin.

“Skin is prone to changes throughout our lives’ journey, be it the smallest of scars from childhood mishaps, acne scars during adolescence, stretch marks from pregnancy, uneven skin tone or pigmentation caused by environmental or hormonal factors, or simply dehydrated and ageing skin. Throughout the years, Bio-Oil which is clinically proven has helped thousands of Malaysians address these skin issues,” said Bio-Oil’s Division Manager of Malaysia and Singapore, Low Hooi Wan.

“The skin is the largest organ of the human body and also one of the most visible, so any flaws on the skin can affect one’s level of self-confidence, especially when it is visible to others. Bio-Oil understands this psychological impact and its purpose is to deliver a solution to bring back skin confidence,” added Low.

Sharing her first hand knowledge on how one’s confidence can be affected by skin imperfections was Dr. Nazirin Ariffin, a consultant dermatologist. In her presentation titled ‘Be Skin Confident Through The Decades,’ she also spoke how topical oils can be used to manage various skin conditions that people face throughout their life.

Suitable even for sensitive skin, Bio-Oil is a unique formulation of seven ingredients—a blend of natural plant oils such as calendula, lavender, rosemary and chamomile; vitamins A and E, and PurCellin Oil™, the breakthrough ingredient that allows skin absorb the goodness quickly, leaving it soft and supple minus the greasy feeling.

A new website www.myskinconfidence.com was launched to give Malaysians easy access to the latest Bio-Oil information and activities.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Dr Lesley Braun, Blackmores Institute Director, is interviewed and answers some critical questions on complementary medicine, its evolution, its benefits and its present and future roles alongside mainstream medicine.
Pearl Toh, 11 days ago
Elderly persons (≥75 years) on aspirin-based antiplatelet therapy without routine proton-pump inhibitor (PPI) use have a higher long-term risk of major bleeding, in particular upper gastrointestinal (GI) bleeding which is often more disabling or fatal than in younger persons, according to the OXVASC* study.
Pearl Toh, 2 months ago
Celecoxib is preferred over naproxen when added to proton-pump inhibitor (PPI) for preventing recurrent upper gastrointestinal (GI) bleeding in patients at high risk of both GI and cardiovascular (CV) events, who require concomitant aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), according to the CONCERN* study.
one year ago
Bicalutamide plus everolimus is a promising treatment for patients with castration-resistant prostate cancer (CRPC), based on a phase II clinical trial.